These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16273222)

  • 1. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
    Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
    Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus.
    Ebrahimi M; Boldrup L; Wahlin YB; Coates PJ; Nylander K
    Oral Oncol; 2008 Jul; 44(7):634-8. PubMed ID: 17936670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DeltaNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2009 Aug; 218(4):428-36. PubMed ID: 19391123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
    Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
    Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous p63 acts as a survival factor for tumour cells of SCCHN origin.
    Thurfjell N; Coates PJ; Vojtesek B; Benham-Motlagh P; Eisold M; Nylander K
    Int J Mol Med; 2005 Dec; 16(6):1065-70. PubMed ID: 16273287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation.
    Ebrahimi M; Wahlin YB; Coates PJ; Sjöström B; Nylander K
    J Oral Pathol Med; 2006 Jan; 35(1):46-50. PubMed ID: 16393253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck.
    Thurfjell N; Coates PJ; Uusitalo T; Mahani D; Dabelsteen E; Dahlqvist A; Sjöström B; Roos G; Nylander K
    Int J Oncol; 2004 Jul; 25(1):27-35. PubMed ID: 15201986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
    Grandis JR; Tweardy DJ
    Cancer Res; 1993 Aug; 53(15):3579-84. PubMed ID: 8339264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
    Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p63 protein and mRNA in oral epithelial dysplasia.
    Chen YK; Hsue SS; Lin LM
    J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
    Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G
    J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
    Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
    Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
    Xi S; Dyer KF; Kimak M; Zhang Q; Gooding WE; Chaillet JR; Chai RL; Ferrell RE; Zamboni B; Hunt J; Grandis JR
    J Natl Cancer Inst; 2006 Feb; 98(3):181-9. PubMed ID: 16449678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function and importance of p63 in normal oral mucosa and squamous cell carcinoma of the head and neck.
    Thurfjell N; Coates PJ; Boldrup L; Lindgren B; Bäcklund B; Uusitalo T; Mahani D; Dabelsteen E; Dahlqvist A; Sjöström B; Roos G; Vojtesek B; Nenutil R; Nylander K
    Adv Otorhinolaryngol; 2005; 62():49-57. PubMed ID: 15608417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
    Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
    Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.